Tellgen Corp (300642) - Total Liabilities

Latest as of September 2025: CN¥472.84 Million CNY ≈ $69.19 Million USD

Based on the latest financial reports, Tellgen Corp (300642) has total liabilities worth CN¥472.84 Million CNY (≈ $69.19 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 300642 cash flow metrics to assess how effectively this company generates cash.

Tellgen Corp - Total Liabilities Trend (2012–2024)

This chart illustrates how Tellgen Corp's total liabilities have evolved over time, based on quarterly financial data. Check 300642 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.

Tellgen Corp Competitors by Total Liabilities

The table below lists competitors of Tellgen Corp ranked by their total liabilities.

Company Country Total Liabilities
Autocanada Inc
TO:ACQ
Canada CA$2.22 Billion
PetroVietnam Transportation Corp
VN:PVT
Vietnam ₫10.82 Trillion
Holtek Semiconductor Inc
TW:6202
Taiwan NT$1.65 Billion
Guangdong Hongteo Accurate Technology Co Ltd
SHE:300176
China CN¥1.37 Billion
PHX Energy Services Corporation
TO:PHX
Canada CA$211.84 Million
VT Industrial Technology Co Ltd
SHE:300707
China CN¥740.87 Million
Vaibhav Global Limited
NSE:VAIBHAVGBL
India Rs6.95 Billion
Jilin Jlu Communication Design Institute Co Ltd
SHE:300597
China CN¥584.24 Million

Liability Composition Analysis (2012–2024)

This chart breaks down Tellgen Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Tellgen Corp (300642) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 11.00 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.32 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.24 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Tellgen Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Tellgen Corp (2012–2024)

The table below shows the annual total liabilities of Tellgen Corp from 2012 to 2024.

Year Total Liabilities Change
2024-12-31 CN¥230.94 Million
≈ $33.79 Million
+60.33%
2023-12-31 CN¥144.05 Million
≈ $21.08 Million
-21.74%
2022-12-31 CN¥184.07 Million
≈ $26.94 Million
+79.43%
2021-12-31 CN¥102.59 Million
≈ $15.01 Million
-2.48%
2020-12-31 CN¥105.19 Million
≈ $15.39 Million
+35.13%
2019-12-31 CN¥77.84 Million
≈ $11.39 Million
-1.07%
2018-12-31 CN¥78.68 Million
≈ $11.51 Million
+100.17%
2017-12-31 CN¥39.31 Million
≈ $5.75 Million
-24.23%
2016-12-31 CN¥51.88 Million
≈ $7.59 Million
+34.84%
2015-12-31 CN¥38.47 Million
≈ $5.63 Million
+25.22%
2014-12-31 CN¥30.72 Million
≈ $4.50 Million
-6.56%
2013-12-31 CN¥32.88 Million
≈ $4.81 Million
+270.61%
2012-12-31 CN¥8.87 Million
≈ $1.30 Million
--

About Tellgen Corp

SHE:300642 China Medical Devices
Market Cap
$392.70 Million
CN¥2.68 Billion CNY
Market Cap Rank
#13773 Global
#4340 in China
Share Price
CN¥16.51
Change (1 day)
+0.30%
52-Week Range
CN¥13.71 - CN¥31.30
All Time High
CN¥46.24
About

Tellgen Corporation researches and develops, manufactures, and distributes IVDs in China and internationally. The company offers tumor markers; cervical cancer and HPV testing kits; Y chromosome microdeletions test kits; autoimmune; tumor methylation; cardiovascular, eugenics, and inflammation. It also provides diagnostic reagents/testing instruments and assembly lines. The company was founded in… Read more